Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 9,030Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Dr. Reddy's Laboratories

02 2American Regent

03 2Amneal Pharmaceuticals

04 2Amphastar Pharmaceuticals

05 2Amring Pharma

06 4Aurobindo Pharma Limited

07 2Avet Pharmaceuticals

08 1B. Braun Medical

09 4Biological E

10 2Caplin Point Laboratories Limited

11 1EQL Pharma

12 3Exela Pharma Sciences, LLC.

13 8Farbe Firma

14 3Fresenius Kabi USA

15 2Fresenius SE & Co. KGaA

16 2GLAND PHARMA LIMITED

17 1Grindeks AS

18 1Hanlim Pharmaceuticals Inc

19 3Hikma Pharmaceuticals

20 1JAMP PHARMA

21 1Labiana Life Sciences S.A

22 1Lifespan Biotech

23 2MARCAN PHARMACEUTICALS INC

24 2Meitheal Pharmaceuticals

25 2Montage Laboratories

26 1ORIFARM GROUP AS

27 3Omega Laboratories Limited

28 2PH HEALTH

29 2Pharmascience Inc.

30 2Pluviaendo

31 1Polifarma

32 2REGCON HOLDINGS

33 1SINTETICA SA

34 2Sagent Pharmaceuticals

35 3Themis Medicare

36 2Umedica Laboratories

37 1Unimedic Pharma Ab

38 3Viatris

39 1Winston Medical Supply

40 1Zhejiang Xianju Pharmaceutical Co. Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/10ML (0.5MG/ML)

Packaging :

Approval Date : 2018-07-10

Application Number : 209135

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 10MG/10ML (1MG/ML)

Packaging :

Approval Date : 2018-07-10

Application Number : 209135

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 3MG/3ML (1MG/ML)

Packaging :

Approval Date : 2022-07-06

Application Number : 216291

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

04

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/10ML (0.5MG/ML)

Packaging :

Approval Date : 2018-05-04

Application Number : 209182

Regulatory Info : DISCN

Registration Country : USA

blank

05

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 10MG/10ML (1MG/ML)

Packaging :

Approval Date : 2018-05-04

Application Number : 209182

Regulatory Info : DISCN

Registration Country : USA

blank

06

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/10ML (0.5MG/ML)

Packaging :

Approval Date : 2018-06-15

Application Number : 210051

Regulatory Info : RX

Registration Country : USA

blank

07

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/10ML (0.5MG/ML)

Packaging :

Approval Date : 2017-09-25

Application Number : 209933

Regulatory Info : RX

Registration Country : USA

blank

08

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 10MG/10ML (1MG/ML)

Packaging :

Approval Date : 2017-09-25

Application Number : 209933

Regulatory Info : RX

Registration Country : USA

blank

09

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/10ML (0.5MG/ML)

Packaging :

Approval Date : 2022-11-25

Application Number : 208230

Regulatory Info : RX

Registration Country : USA

blank

10

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 10MG/10ML (1MG/ML)

Packaging :

Approval Date : 2022-11-25

Application Number : 208230

Regulatory Info : RX

Registration Country : USA

blank

11

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : BLOXIVERZ

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/10ML (0.5MG/ML)

Packaging :

Approval Date : 2013-05-31

Application Number : 204078

Regulatory Info : RX

Registration Country : USA

blank

12

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : BLOXIVERZ

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 10MG/10ML (1MG/ML)

Packaging :

Approval Date : 2013-05-31

Application Number : 204078

Regulatory Info : RX

Registration Country : USA

blank

13

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : BLOXIVERZ

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/5ML (1MG/ML)

Packaging :

Approval Date : 2023-10-27

Application Number : 204078

Regulatory Info : RX

Registration Country : USA

blank

14

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/10ML (0.5MG/ML)

Packaging :

Approval Date : 2015-01-08

Application Number : 203629

Regulatory Info : RX

Registration Country : USA

blank

15

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 10MG/10ML (1MG/ML)

Packaging :

Approval Date : 2015-01-08

Application Number : 203629

Regulatory Info : RX

Registration Country : USA

blank

16

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 3MG/3ML (1MG/ML)

Packaging :

Approval Date : 2018-09-18

Application Number : 203629

Regulatory Info : RX

Registration Country : USA

blank

17

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/10ML (0.5MG/ML)

Packaging :

Approval Date : 2015-12-28

Application Number : 207042

Regulatory Info : RX

Registration Country : USA

blank

18

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 10MG/10ML (1MG/ML)

Packaging :

Approval Date : 2015-12-28

Application Number : 207042

Regulatory Info : RX

Registration Country : USA

blank

19

PH HEALTH

Country
AIChE Annual Meeting
Not Confirmed
arrow

PH HEALTH

Country
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5MG/10ML (0.5MG/ML)

Packaging :

Approval Date : 2017-04-26

Application Number : 208405

Regulatory Info : RX

Registration Country : USA

blank

20

PH HEALTH

Country
AIChE Annual Meeting
Not Confirmed
arrow

PH HEALTH

Country
arrow
AIChE Annual Meeting
Not Confirmed

NEOSTIGMINE METHYLSULFATE

Brand Name : NEOSTIGMINE METHYLSULFATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 10MG/10ML (1MG/ML)

Packaging :

Approval Date : 2017-04-26

Application Number : 208405

Regulatory Info : RX

Registration Country : USA

blank